United States · FDA National Drug Code directory

GaviLyte-H and Bisacodyl

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 43386-071_c34cfe17-96c2-4f07-8a2d-74bc84e61fb4
Product NDC: 43386-071
Form: KIT
Composition / generic term: Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet
Labeler: Lupin Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20150421
Source listing expiry: 20261231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

1 KIT in 1 KIT (43386-071-83) * 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (43386-010-61) * 2 L in 1 BOTTLE (43386-070-17) · 43386-071-83

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →